A new model to predict response to direct-acting antiviral therapy in decompensated cirrhotics due to hepatitis C virus

AIM: of the study: Decompensated hepatitis C virus (HCV) cirrhosis is a difficult to treat cohort, and there is no gold standard predictor of response to direct-acting antiviral (DAA) therapy. We conducted this study to look for factors responsible for improvement in post-therapy status, i.e. attain...

Descripción completa

Detalles Bibliográficos
Autores principales: Debnath, Prasanta, Chandnani, Sanjay, Rathi, Pravin, Nair, Sujit, Junare, Parmeshwar, Udgirkar, Suhas, Singh, Anupam, Contractor, Qais
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592091/
https://www.ncbi.nlm.nih.gov/pubmed/33145432
http://dx.doi.org/10.5114/ceh.2020.99525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592091/
https://www.ncbi.nlm.nih.gov/pubmed/33145432
http://dx.doi.org/10.5114/ceh.2020.99525

Ejemplares similares